AMEX Healthcare Medical - Instruments & Supplies MLSS

Milestone Scientific Inc.

$ 0.37 9.24 %

Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.

CEO: Eric C. Hines - https://www.milestonescientific.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

$4 977.30 %

Recommandation

Buy

DCF

$ -1.13

Loading data...

MLSS vs S&P500

Loading data...

No data available.

Quick ratio

0.79

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

-6.19

may indicate that the company is undervalued or has poor growth prospects.

EPS

-0.06

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-166.28 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-138.42 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

8.97

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.43

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

-0.02

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
2 indicates worrying financial health
Altman score
-20.59 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.25 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.12 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.